Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Treated mice show a 15%20% increase in basal metabolic rate and elevated energy expenditure, with effects positively correlated with NNMT inhibition
Contact us today to schedule an appointment
For glaucoma and eye problems: BPC-157 has shown efficacy in many animal studies and a couple of preclinical trials for eye problems
For example, in the elderly population, as they age, the function of their throat muscles may decline, making it difficult to swallow solid medications
BPC-157 tackles this problem directly by: Stimulating neoangiogenesis within the tendon or ligament substance Activating tenocytes (tendon cells) to produce organized collagen Reducing fibrotic adhesion formation that limits range of motion Condition-by-Condition Clinical Applications Tendinopathies Chronic tendon conditionsAchilles, patellar, rotator cuff, lateral epicondyle (tennis elbow), medial epicondyle (golfers elbow)respond exceptionally well to BPC-157
Published Phase 2 clinical trial data used doses of 1mg, 4mg, 8mg, and 12mg administered weekly via subcutaneous injection
US$ 24.13
US$ 27.86
US$ 29.05
US$ 20.77
US$ 21.38
US$ 27.87
US$ 28.97
US$ 23.44
US$ 29.90
